Similar articles

• Atherogenesis in transgenic mice expressing human apolipoprotein(a).

  Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM. Lawn RM, et al. Nature. 1992 Dec 17;360(6405):670-2. doi: 10.1038/360670a0. Nature. 1992. PMID: 1465128
• Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.

  Boffa MB, Marcovina SM, Koschinsky ML. Boffa MB, et al. Clin Biochem. 2004 May;37(5):333-43. doi: 10.1016/j.clinbiochem.2003.12.007. Clin Biochem. 2004. PMID: 15087247 Review.
• Transgenic rabbits expressing human apolipoprotein(a) as a useful model for the study of lipoprotein(a).

  Fan J, Challah M, Shimoyamada H, Watanabe T. Fan J, et al. Ann N Y Acad Sci. 2000 May;902:347-51. doi: 10.1111/j.1749-6632.2000.tb06336.x. Ann N Y Acad Sci. 2000. PMID: 10865861 No abstract available.
• The role of apolipoproteins in lipid metabolism and atherogenesis: aspects in man and mice.

  Kreuzer J, von Hodenberg E. Kreuzer J, et al. J Hypertens. 1994 Feb;12(2):113-8. J Hypertens. 1994. PMID: 8021461 Review. No abstract available.
• Male-associated hypertension in LDL-R deficient mice.

  Trieu VN, Uckun FM. Trieu VN, et al. Biochem Biophys Res Commun. 1998 Jun 18;247(2):277-9. doi: 10.1006/bbrc.1998.8776. Biochem Biophys Res Commun. 1998. PMID: 9642116